|
|
Abdelaziz Amrani, Joan Verdaguer, Brad Anderson, Toshihiro Utsugi, Sonny Bou, Pere Santamaria
J Clin Invest. 1999;
103(8):1201
doi:10.1172/JCI6266
Abstract |
Full text
| PDF

A
utoimmune diabetes in nonobese diabetic (NOD) mice results from destruction of pancreatic β cells by T lymphocytes. It is believed that CD8+ cytotoxic T lymphocytes (CTLs) effect the initial β-cell insult in diabetes, but the mechanisms remain unclear. Studies of NOD.lpr mice have suggested that disease initiation is a Fas-dependent process, yet perforin-deficient NOD mice rarely develop diabetes despite expressing Fas. Here, we have investigated the role of perforin and Fas in the ability of β cell–reactive CD8+ T cells bearing a T-cell receptor (8.3-TCR) that is representative of TCRs used by CD8+ CTLs propagated from the earliest insulitic lesions of NOD mice, and that targets an immunodominant peptide/H-2Kd complex on β cells, to effect β-cell damage in vitro and in vivo. In vitro, 8.3-CTLs killed antigenic peptide–pulsed non–β-cell targets via both perforin and Fas, but they killed NOD β cells via Fas exclusively. Perforin-deficient 8.3-TCR–transgenic NOD mice expressing an oligoclonal or monoclonal T-cell repertoire developed diabetes even more frequently than their perforin-competent littermates. These results demonstrate that diabetogenic CD8+ CTLs representative of CTLs putatively involved in the initiation of autoimmune diabetes kill β cells in a Fas-dependent and perforin-independent manner.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
About CrossRef
| Title and authors |
Publication |
Year |
. |
The Type 1 Diabetes PhysioLab® Platform: a validated physiologically based mathematical model of pathogenesis in the non-obese diabetic mouse
L. Shoda, H. Kreuwel, K. Gadkar, Y. Zheng, C. Whiting, M. Atkinson, J. Bluestone, D. Mathis, D. Young, S. Ramanujan |
Clin Exp Immunol |
2010 |
.
|
The role of perforin and granzymes in diabetes
H E Thomas, J A Trapani, T W H Kay |
Cell Death Differ |
2009 |
.
|
Intracellular versus extracellular granzyme B in immunity and disease: challenging the dogma
Wendy Anne Boivin, Dawn Michelle Cooper, Paul Ryan Hiebert, David James Granville |
Lab Invest |
2009 |
.
|
Beta cell apoptosis in diabetes
Helen E. Thomas, Mark D. McKenzie, Eveline Angstetra, Peter D. Campbell, Thomas W. Kay |
APOPTOSIS |
2009 |
.
|
Cytotoxic T-lymphocyte–mediated killing of human pancreatic islet cells in vitro
Peter D. Campbell, Eugene Estella, Nadine L. Dudek, Gaurang Jhala, Helen E. Thomas, Thomas W.H. Kay, Stuart I. Mannering |
human immunol |
2008 |
.
|
Innate immunity and intestinal microbiota in the development of Type 1 diabetes
Li Wen, Ruth E. Ley, Pavel Yu. Volchkov, Peter B. Stranges, Lia Avanesyan, Austin C. Stonebraker, Changyun Hu, F. Susan Wong, Gregory L. Szot, Jeffrey A. Bluestone, Jeffrey I. Gordon, Alexander V. Chervonsky |
j nature |
2008 |
.
|
In vivo effects of cytokines on pancreatic β-cells in models of type I diabetes dependent on CD4+ T lymphocytes
Eveline Angstetra, Kate L Graham, Sarah Emmett, Nadine L Dudek, Rima Darwiche, Rochelle Ayala-Perez, Janette Allison, Pere Santamaria, Thomas W H Kay, Helen E Thomas |
Aust J Exp Biol Med |
2008 |
.
|
The vicious cycle of apoptotic β-cell death in type 1 diabetes
Ayelet Kaminitz, Jerry Stein, Isaac Yaniv, Nadir Askenasy |
Aust J Exp Biol Med |
2007 |
.
|
A Critical Role for Granzyme B, in Addition to Perforin and TNF??, in Alloreactive CTL-Induced Mouse Pancreatic Beta Cell Death
Vivien R. Sutton, Eugene Estella, Chi Li, Melanie Chen, Helen E. Thomas, Thomas W. Kay, Joseph A. Trapani |
Transplantation |
2006 |
.
|
Effect of Antibody to CD134 on Perforin-Mediated Cytolysis in Human Peripheral Blood Mononuclear Cells
Ming Li, Yuanchao Zhang |
Hybridoma (Larchmt) |
2006 |
.
|
The Role of Fas Ligand in Beta Cell Destruction in Autoimmune Diabetes of NOD Mice
N. PETROVSKY, D. SILVA, L. SOCHA, R. SLATTERY, B. CHARLTON |
Annals of the New York Academy of Sciences |
2006 |
.
|
The dual role of Fas-ligand as an injury effector and defense strategy in diabetes and islet transplantation
Michal Pearl-Yafe, Esma S. Yolcu, Isaac Yaniv, Jerry Stein, Haval Shirwan, Nadir Askenasy |
Bioessays |
2006 |
.
|
Impaired IL-4 production by CD8+ T?cells in NOD mice is related to a defect of c-Maf binding to the IL-4 promoter
Xiao-Ping Chen, Dewayne?H. Falkner, Penelope?A. Morel |
Eur J Immuno |
2005 |
.
|
Death effectors of β-cell apoptosis in type 1 diabetes
Myung-Shik Lee, Inik Chang, Sunshin Kim |
Mol Genet Metab |
2004 |
.
|
Genevieve de Saint Basile, Alain Fischer |
Current Opinion in Rheumatology |
2003 |
.
|
Kinetic Evolution of a Diabetogenic CD8+ T Cell Response
PERE SANTAMARIA |
New York Academy of Science |
2003 |
.
|
IL-1α, IL-1β, and IFN-γ mark β cells for Fas-dependent destruction by diabetogenic CD4+ T lymphocytes
Abdelaziz Amrani, Joan Verdaguer, Shari Thiessen, Sonny Bou, Pere Santamaria |
Journal Clinical Investigation |
2000 |
.
|
Beta cell destruction in the development of autoimmune diabetes in the non-obese diabetic (NOD) mouse
Helen E. Thomas, Thomas W. H. Kay |
Diabetes Metab Res |
2000 |
.
|
|
|
|